Lupin’s Somerset Manufacturing Plant receives EIR from US FDA.
Lupin
Posted inSectors
Lupin gets approval from U.S. FDA for Sildenafil for Oral Suspension Â
Sildenafil for Oral Suspension, 10 mg/mL has an estimated annual sales of USD 66 million in the U.S.
Posted inSectors
Lupin unveils its first Reference Laboratory in East India
Diagnostics services to doctors, patients and consumers from Lupin coming up in West Bengal, Assam, Bihar, Jharkhand and Orissa.
Posted inPeople
Lupin announces change in executive leadership
Dr Fabrice Egros to assume responsibility as President, Global Corporate Development & Growth Markets.
Posted inSectors
Lupin signs promotional agreement with Exeltis on SOLOSEC
Expands access for adult women suffering with Bacterial Vaginosis and adults with Trichomoniasis.
Posted inSectors
Lupin introduces Molnupiravir under the brand name Molnulup for treatment of COVID-19
Clinical data points to its effectivity on patients with co-morbidities.
Posted inSectors
Lupin gets tentative approval from U.S. FDA for Azilsartan Medoxomil Tablets
Product to be manufactured at Lupin’s Nagpur facility in India.